News & Articles
Selected Filters:
EKF Diagnostics Highlight New Clinical Chemistry Analyzer at Arab Health 2016
Point-of-care and lab diagnostics products on show at EKF's Stand Z1G30, Zabeel Hall 1
EKF Diagnostics Publishes “Anemia and Hemoglobin Testing” Guide
Detailed hematology guide available for free download
Novel EKF Biomarker Identifies People Likely to Develop Diabetic Nephropathy
New data paves way for adoption of sTNFR1 as a routine test for Diabetic Nephropathy management
European Launch of EKF’s New Clinical Chemistry Analyzer at Medica 2015
The Altair™ 240 fully automated, cost-effective platform with feature-rich functionality
EKF’s PointMan™ Used in Successful Liquid Biopsy Research
Comparative study of tumor biopsy v noninvasive blood-based analyses published
EKF’s Unique and Simple Creamatocrit Analyzer Highlighted at FIGO
Inexpensive and accurate analysis of mother’s milk fat and calories ideal for neonatal ICU
New Data Published on PointMan™ DNA Enrichment Technology for Highly Sensitive Lung Cancer Mutation Detection
Studies confirm utility of PointMan for molecular analysis of CTCs and circulating DNA in liquid biopsies
EKF’s new Altair™240 Clinical Chemistry Analyzer Revealed to UK Audience at IBMS 2015
The new Altair™ 240 fully automated analyzer designed with Stanbio chemistry products in mind
New Bench-Top Clinical Chemistry Analyzer Launched by EKF Diagnostics at AACC 2015
The new Altair™ 240 fully automated, cost-effective platform designed with Stanbio Chemistry products in mind
EKF Diagnostics to Showcase Comprehensive Clinical Chemistry Range at AACC 2015
To find out more about their comprehensive range of clinical chemistry, visit them at booth #1018.
EKF Diagnostics Highlighting Cancer Molecular Diagnostics Products at ASCO 2015
New PrecisionPath™ NGS panel molecular test for colon cancer to be key focus on Booth #19141
New Affordable Advanced NGS Cancer Test Launched by EKF Subsidiary
Selah and GHS partner to pave the way for accessible, low-cost personalized medicine
EKF Highlighting its Expanding Range of Liquid Stable Clinical Chemistry Reagents at Hospitalar 2015
New diabetes and sepsis biomarkers introduced to South America at Stand K77, Hospitalar 2015, Sao Paulo, Brazil
EKF Introduces Specific Biomarker Test for Early Sepsis Identification
The EKF-Stanbio Procalcitonin LiquiColor® Assay aids in viral and bacterial infection differentiation
EKF Launches Next Generation Hemo Control POC Hemoglobin Analyzer
New Hemo Control uniquely ensures bi-directional data management future proofing
Data Presented at AACR 2015 Recognizes Value of EKF PointMan Technology for Assessing Lung Cancer Mutation Status
PointMan used for non-invasive analysis for T790M mutations of EGFR